Learn more about our upcoming Galas and Signature Events Learn More
Superyacht Captain, TV Personality, Melanoma Patient and Advocate Poised to Emcee Event Honoring the Melanoma Community New York City, NY (September 11, 2025) – The...
Today, the board of directors of the Melanoma Research Foundation announced Kyleigh LiPira, MBA as the MRF’s new Chief Executive Officer. LiPira was promoted from her...
Guest blog post by melanoma survivor and MRF volunteer advocate, Wayne Conners: Much of the time, people begin their melanoma stories something like this: “In March 2...
As we cross the finish line for the 2017 season, the MRF's Miles for Melanoma team is reminded of the wonderful memories, powerful experiences and dedicated individuals...
#EyeGetDilated because… I want to continue exploring the world with my mom. I know this statement may not exactly make sense, so let me explain.
J.B. Ward is one of the 1% of melanoma patients with mucosal melanoma. Together, J.B., the MRF and the mucosal melanoma community have launched a mucosal melanoma fundraisi...
Guest blog post by OM survivor and #EyeGetDilated advocate, Deborah Smith: I am Deborah Smith from Georgia and I have a Class II choroidal melanoma tumor. My walk with canc...
Guest blog post by OM survivor and #EyeGetDilated advocate, William Karp: My OM journey began so quietly that I didn't know I was even on a journey. For a long time, I ...
Ocular melanoma survivor and 2017 MRF Courage Award recipient Aaron Davis on the importance of “near life experiences.”
The Board of Directors of the Melanoma Research Foundation (MRF) is excited to announce that Eleanor (Elly) Brtva will assume the role of CEO of the Melanoma Research ...
Since 1992, the Department of Defense Congressionally-Directed Medical Research Program (CDMRP) has transformed healthcare for service members and the American public ...
The Melanoma Reserach Foundation (MRF) is now accepting applications for the 2018 Medical Student Research Award. The MRF has been awarding this research grant since 2011 a...
Last week the United States Food and Drug Administration (FDA) expanded approval of Yervoy (ipilimumab) to include pediatric patients ages 12 years and older with unresecta...
Oct 30, 2025 ET
